Inhibition of these proteins resulted in the downregulation of DNMT1 and a decreased clonogenic potential of cancers cells in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) (128–130). This evidence concerns the gene DNMT1 and chronic myelogenous leukemia, BCR-ABL1 positive.